chronic granulocytic leukemia course

Written by He Li Fang
Hematology
Updated on September 27, 2024
00:00
00:00

The course of chronic granulocytic leukemia is relatively long, as it is a type of chronic leukemia. Its onset is gradual, and its natural course includes four stages: asymptomatic phase, chronic phase, accelerated phase, and blast crisis phase. Most patients seek medical attention and are diagnosed only after symptoms appear, with very few patients discovering blood abnormalities during physical examinations or blood tests conducted for other reasons. At this point, the spleen may already be mildly enlarged, or not enlarged at all. In the early stages of the disease, some patients may experience an absolute increase in basophilic granulocytes. When the white blood cell count is less than 20×10^9/L, there is a decrease in neutrophil alkaline phosphatase activity in peripheral blood, and this decreases further as the disease progresses. When the white blood cell count exceeds 40×10^9/L, the spleen can be felt below the ribs. Between 30 and 90×10^9/L, a range of related clinical symptoms may appear.

Other Voices

doctor image
home-news-image
Written by He Li Fang
Hematology
1min 56sec home-news-image

Chronic granulocytic leukemia etiology

Chronic granulocytic leukemia is a myeloproliferative tumor originating from multipotent stem cells. It is characterized by the translocation of chromosomes 9 and 22 forming the BCR/ABL fusion gene. The Philadelphia chromosome is a characteristic change in chronic granulocytic leukemia, first discovered and named in Philadelphia in 1960. Initially, it was observed as a deletion of the long arm of the primary chromosome in dividing blood cells of patients with this leukemia. Currently, studies have shown that abnormalities in the interaction between hematopoietic progenitor cells and the stroma might be central to treating the disease. Abnormal adhesion and anchoring characteristics of progenitor cells lead to disrupted cell maturation and proliferation. Chronic granulocytic cells do not adhere to stromal cells as normal cells do, particularly lacking integrin-mediated adhesion. Additionally, the expression of the adhesion molecule lymphocyte function-associated antigen 3 is also reduced in these cells. Therefore, the progression of the disease results from clonal changes. During the transformation of chronic granulocytic leukemia to acute myeloid leukemia, there is an increased rate of genetic mutations. Changes in gene expression during the progression involve various aspects, including nucleosome sugar metabolism, bone marrow myeloid differentiation, genomic instability of cell apoptosis genes, and processes related to DNA damage repair.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
38sec home-news-image

Does leukemia cause vomiting?

Leukemia can cause vomiting. There are two reasons why leukemia patients experience vomiting: one is caused by the leukemia itself. If the white blood cell count in leukemia patients abnormally increases to more than 100×10^9/L, this condition is called hyperleukocytosis. In the state of hyperleukocytosis, the body is in a state of ischemia and hypoxia, which can manifest as dizziness, headache, and vomiting in the nervous system. The other reason is that during chemotherapy, the use of chemotherapy drugs can lead to gastrointestinal reactions such as nausea and vomiting.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
53sec home-news-image

Symptoms of Acute Leukemia

The common symptoms of acute leukemia include four main categories: infection, anemia, bleeding, and tumor infiltration. Symptoms of infection manifest as fever, cough, expectoration, chest pain, abdominal pain, diarrhea, frequent urination, urgent urination, painful urination, skin infections, and perianal infections. Anemia is characterized by dizziness, fatigue, poor appetite, and decreased endurance. Symptoms of reduced platelets mainly involve bleeding, which can manifest as bleeding of the skin and mucous membranes, organ bleeding, and even cerebral hemorrhage. Tumor infiltration can manifest as gingival hyperplasia and skin rashes among other swellings.

doctor image
home-news-image
Written by He Li Fang
Hematology
1min 18sec home-news-image

What is leukemia?

Leukemia is a malignant tumor of the hematopoietic system that originates from hematopoietic stem/progenitor cells. It involves leukemia cells that have proliferative and survival advantages, proliferating and accumulating uncontrollably in the body, gradually replacing normal hematopoiesis to form pathological hematopoiesis. Furthermore, it invades other organs and systems, leading to symptoms such as anemia, bleeding, and infections, which eventually cause death. The incidence of leukemia is 4.8/100000-7.1/100000 in males and 3.2/100000-4.6/100000 in females, with significant variations in incidence, mortality rates, and distribution among different types of leukemia and various regions and ethnic groups. Early on, it was recognized that leukemia is not an inflammation, and the views that leukemia is caused by a lack of certain substances have been proven incorrect. Currently, it is understood that the causative factors of leukemia are related to infections, radiation, chemical agents, lifestyle, and genetics.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
52sec home-news-image

Can leukemia be cured?

Leukemia is a broad category of diseases. Some leukemia patients can achieve clinical cure through oral chemotherapy or intravenous chemotherapy, while others can only achieve cure through allogeneic hematopoietic stem cell transplantation. Among them, chronic granulocytic leukemia can be clinically cured through oral chemotherapy due to the availability of targeted drug treatments, resulting in a longer survival period. In the case of acute promyelocytic leukemia, the advent of drugs like retinoic acid and arsenic trioxide has enabled patients to achieve clinical cure through a combination of oral and intravenous chemotherapy. However, many other types of leukemia often require allogeneic hematopoietic stem cell transplantation to reach clinical cure.